Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Anticipating Flotek Industries Quarterly Financial Results A Look at Past Performance and Market Expectations

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Flotek Industries, a company listed on the NYSE under the ticker symbol FTK, is set to unveil its quarterly financial results on March 12, 2024. Analysts are anticipating an earnings per share (EPS) of $0.09 for the company. Investors are eagerly waiting to see if Flotek Industries will exceed this forecast and provide optimistic guidance for future growth. It is worth noting that guidance often has a more significant impact on stock prices than beating or missing earnings estimates.

Looking back at the previous quarter, Flotek Industries outperformed EPS expectations by $0.03, resulting in an 11.27% drop in share price the following day. Here is a summary of Flotek Industries’ EPS estimates, actual results, and corresponding price changes in recent quarters:

Q3 2023: EPS Estimate 0.01, EPS Actual 0.04, Price Change -11.0%
Q2 2023: EPS Estimate -0.12, EPS Actual -0.12, Price Change -4.0%
Q1 2023: EPS Estimate -0.48, EPS Actual -0.12, Price Change 5.0%
Q4 2022: EPS Estimate -0.42, EPS Actual -1.50, Price Change -14.00%

On March 8, Flotek Industries’ shares were trading at $2.79, reflecting a 53.47% decline over the past year. With this negative trend in mind, long-term investors may be approaching the upcoming earnings release with caution and pessimism.

For more comprehensive information on Flotek Industries’ earnings announcements and financial performance, you can refer to their earnings calendar on Benzinga’s website.

Flotek Industries Inc. (FTK) Stock Performance Declines on March 11, 2024: Analysis and Insights

On March 11, 2024, Flotek Industries Inc. (FTK) experienced a decline in its stock performance. The stock opened at $2.82, which was $0.03 higher than its previous close. Throughout the trading day, FTK shares dropped by $0.07, representing a 2.51% decrease from the previous close.

FTK Stock Performance Analysis: Revenue Increase but Net Loss Reported on March 11, 2024

On March 11, 2024, the stock performances of FTK were closely scrutinized by investors and analysts following the release of the company’s financial data. FTK reported a total revenue of $136.09 million over the past year, a significant increase of 214.53% compared to the previous year. However, the total revenue for the third quarter of the year stood at $47.27 million, indicating a decrease of 6.57% since the previous quarter.

In terms of net income, FTK reported a net loss of $42.30 million over the past year, showing a decrease of 38.59% compared to the previous year. However, the net income for the third quarter of the year was $1.29 million, representing a substantial increase of 6228.57% since the previous quarter.

Earnings per share (EPS) for FTK were reported at -$3.41 over the past year, reflecting a decrease of 36.6% compared to the previous year. However, the EPS for the third quarter of the year was $0.04, showing an increase of 137.18% since the previous quarter.

The fluctuating financial performance of FTK has undoubtedly impacted its stock prices on March 11, 2024. Investors may have reacted differently to the contrasting figures of revenue, net income, and EPS over the past year and the third quarter of the year. The significant increase in total revenue over the past year may have initially sparked optimism among investors, but the decrease in revenue since the previous quarter could have raised concerns about the company’s growth prospects.

Similarly, the contrasting trends in net income and EPS between the past year and the third quarter of the year may have further influenced investors’ decisions regarding FTK stock. The substantial increase in net income and EPS since the previous quarter could have potentially reassured investors about the company’s financial stability and performance.

Overall, the stock performances of FTK on March 11, 2024, were likely influenced by the company’s financial data, particularly the fluctuations in total revenue, net income, and EPS over the past year and the third quarter of the year. Investors and analysts will continue to closely monitor FTK’s financial performance to assess its future growth potential and stock value.

Tags: FTK
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Caesars Sportsbook Launches Mobile Wagering in North Carolina

Entertainment Trading online

Lions Gate Entertainment Corp Announces Merger with Screaming Eagle Acquisition Corp Creating Lionsgate Studios Corp

Healthcare-and-IT

Revolutionizing Medical Treatment A Groundbreaking Discovery

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com